Heo Eun-cheol, CEO of GC Pharma, stated in his New Year's address on the 2nd, "I believe in the solid power of GC Pharma, which has begun to soar with its two wings despite the rapidly changing world situation and unstable domestic environment, and this year will be even more promising than last year."
CEO Heo noted, "In 2024, which was the inaugural year for our global expansion, we focused our capabilities to achieve our company-wide goal of establishing 'Aliglo' in the U.S. market, and thanks to everyone coming together with enthusiasm, we were able to reap results beyond our expectations. All these achievements belong to the employees who did their best last year, and they are a source of pride for all of us."
He added, "The two traditional pillars of vaccines and blood products, the two challenging areas of over-the-counter medications and primary care for chronic diseases, and the two expanded grounds of domestic and global will complement and drive each other, and I am confident that they will become a strong force leading us through crises and into growth."
He further emphasized, "While nothing has been easy, we have risen to the status of a global corporation with a mission to develop 'difficult-to-make drugs, but essential drugs,' even in challenging environments. Although we may still lack in scale and experience, the gap will quickly close, and the time when we can fully demonstrate our capabilities is coming soon."
CEO Heo stated, "Our ultimate goal is not to follow but to lead. The second and third new drugs will succeed in overseas markets consecutively, the world will become our workplace, and the day will surely come when we establish ourselves as a leading global pharmaceutical corporation."